According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of โน0.61 Billion, an increase over its 2022 earnings that were of -โน3.16 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | โน2.05 B | 234.26% |
2023 | โน0.61 B | -119.45% |
2022 | -โน3.16 Billion | 39.17% |
2021 | -โน2.27 Billion | 73.93% |
2020 | -โน1.31 Billion | 18.53% |
2019 | -โน1.1 Billion | -16.62% |
2018 | -โน1.32 Billion | 38.32% |
2017 | -โน0.96 Billion | 12.51% |
2016 | -โน0.85 Billion | 25.01% |
2015 | -โน0.68 Billion | 18.18% |
2014 | -โน0.58 Billion | 39.72% |
2013 | -โน0.42 Billion | 46.4% |
2012 | -โน0.29 Billion | 128.32% |
2011 | -โน0.13 Billion | -51.47% |
2010 | -โน0.26 Billion | 35.21% |
2009 | -โน0.19 Billion | |
2007 | -โน0.3 Billion | 607.04% |
2006 | -โน41.64 Million |